Mark S. Forman

Insider Reports History

Entity
Individual
Location
C/O Passage Bio, Inc., 2005 Market Street, 39 Th Floor, Philadelphia, PA
Signature
/s/ Austin Rutherford, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark S. Forman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Passage BIO, Inc. CHIEF MEDICAL OFFICER Common Stock 48.6K $47.2K $0.97 Feb 13, 2024 Direct
Passage BIO, Inc. CHIEF MEDICAL OFFICER Restricted Stock Unit 10K $9.1K $0.91 Feb 10, 2024 Direct
Ventyx Biosciences, Inc. Chief Medical Officer Stock Option (Right to Buy) 350K Aug 12, 2024 Direct
Passage BIO, Inc. CHIEF MEDICAL OFFICER Employee Stock Option (right to buy) 203K Mar 15, 2024 Direct

Insider Reports Filed by Mark S. Forman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VTYX Ventyx Biosciences, Inc. Aug 12, 2024 1 $0 4 Aug 13, 2024 Chief Medical Officer
VTYX Ventyx Biosciences, Inc. Aug 12, 2024 0 $0 3 Aug 13, 2024 Chief Medical Officer
PASG Passage BIO, Inc. Mar 15, 2024 1 $0 4 Mar 19, 2024 CHIEF MEDICAL OFFICER
PASG Passage BIO, Inc. Dec 31, 2023 3 -$14.4K 4 Jan 3, 2024 Chief Medical Officer
PASG Passage BIO, Inc. Mar 15, 2023 1 $0 4 Apr 5, 2023 Chief Medical Officer
PASG Passage BIO, Inc. Nov 10, 2022 1 $0 4 Nov 14, 2022 Chief Medical Officer
PASG Passage BIO, Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Chief Medical Officer
PASG Passage BIO, Inc. Apr 18, 2022 1 $0 4 Apr 20, 2022 Chief Medical Officer
PASG Passage BIO, Inc. Mar 30, 2022 0 $0 3 Apr 8, 2022 Chief Medical Officer
PASG Passage BIO, Inc. Aug 16, 2021 6 -$1.59K 4 Feb 13, 2024 CHIEF MEDICAL OFFICER